Study of MEHMO Syndrome and Related eIF2-Pathway Conditions Tracking Symptoms, Biomarkers, and Disease Progression

What this Trial Is About

Researchers are studying individuals with MEHMO syndrome or related eIF2-pathway conditions, which involve symptoms like intellectual delay, seizures, hormone and blood sugar abnormalities, and reduced motor skills. This observational natural history study aims to better understand the disease progression and identify markers to monitor these rare conditions, as no treatments currently exist. The study also seeks to develop tools for diagnosis, severity rating, and future research resources. Participants include affected individuals, carriers, and unaffected family members. The study involves general health assessments, imaging, laboratory tests, and collection of samples such as blood, urine, spinal fluid, and skin biopsies. Data and biomaterials will be collected longitudinally to compare affected, carrier, and unaffected groups. Throughout the study, participants will undergo evaluations to characterize disease presentation and identify biomarkers. Researchers will assess the feasibility of study procedures and develop severity scales. A repository of participant data and samples will be created to support future research. The study is ongoing and follows participants over an extended period with regular assessments.

MEHMO Natural History and Biomarkers